Drugs and drug delivery systems targeting amyloid-β in Alzheimer's disease

Drugs and drug delivery systems targeting amyloid-β in Alzheimer's disease

Alzheimer's disease (AD) is a devastating neurodegenerative disorder with no cure and limited treatment solutions that are unable to target any of the suspected causes. Increasing evidence suggests that one of the causes of neurodegeneration is the overproduction of amyloid beta (Aβ) and the in...

Full description

Bibliographic Details
Main Authors:	Morgan Robinson, Brenda Yasie Lee, Zoya Leonenko
Format:	Article
Language:	English
Published:	AIMS Press 2015-07-01
Series:	AIMS Molecular Science
Subjects:	amyloid amyloid aggregation inhibitor drugs Alzheimer's disease drug delivery systems blood brain barrier nanotechnology
Online Access:	http://www.aimspress.com/Molecular/article/349/fulltext.html

Similar Items

Effect of Metals on Kinetic Pathways of Amyloid-β Aggregation
by: Francis Hane, et al.
Published: (2014-01-01)

Small-Molecule Amyloid Beta-Aggregation Inhibitors in Alzheimer's Disease Drug Development
by: Sharmin Reza Chowdhury, et al.
Published: (2019-08-01)

Effect of Varying Concentrations of Docosahexaenoic Acid on Amyloid Beta (1–42) Aggregation: An Atomic Force Microscopy Study
by: Brenda Yasie Lee, et al.
Published: (2018-11-01)

Pseudopeptide Amyloid Aggregation Inhibitors: In Silico, Single Molecule and Cell Viability Studies
by: Morgan Robinson, et al.
Published: (2021-01-01)

Islet amyloid polypeptide & amyloid beta peptide roles in Alzheimer’s disease: two triggers, one disease
by: Sofia Ferreira, et al.
Published: (2021-01-01)

Screening for Novel Inhibitors of Amyloid Beta Aggregation and Toxicity as Potential Drugs for Alzheimer’s Disease
by: Sanaa Sharari, et al.
Published: (2023-07-01)

Recent Computational Advances Regarding Amyloid-β and Tau Membrane Interactions in Alzheimer’s Disease
by: Phuong H. Nguyen, et al.
Published: (2023-10-01)

Application of Amyloid-Based Hybrid Membranes in Drug Delivery
by: You-Ren Lai, et al.
Published: (2023-03-01)

The Early Events That Initiate β-Amyloid Aggregation in Alzheimer’s Disease
by: Xingyu Zhang, et al.
Published: (2018-11-01)

Linking the Amyloid, Tau, and Mitochondrial Hypotheses of Alzheimer’s Disease and Identifying Promising Drug Targets
by: Zdeněk Fišar
Published: (2022-11-01)

Biflavonoid-Induced Disruption of Hydrogen Bonds Leads to Amyloid-β Disaggregation
by: Peter K. Windsor, et al.
Published: (2021-03-01)

Potential Role of Nanoparticles in Treating the Accumulation of Amyloid-Beta Peptide in Alzheimer’s Patients
by: Mohamed Abbas
Published: (2021-03-01)

Preparation and study of the inhibitory effect of nano-niosomes containing essential oil from artemisia absinthium on amyloid fibril formation
by: Mojtaba Ansari, et al.
Published: (2020-07-01)

Bacterial Extracellular DNA Promotes β-Amyloid Aggregation
by: George Tetz, et al.
Published: (2021-06-01)

Different aspects of Alzheimer’s disease-related amyloid β-peptide pathology and their relationship to amyloid positron emission tomography imaging and dementia
by: Dietmar Rudolf Thal, et al.
Published: (2019-11-01)

Development and Evaluation of Solid Lipid Nanoparticles for the Clearance of Aβ in Alzheimer’s Disease
by: Meghana Goravinahalli Shivananjegowda, et al.
Published: (2023-01-01)

New Multitarget Rivastigmine–Indole Hybrids as Potential Drug Candidates for Alzheimer’s Disease
by: Leo Bon, et al.
Published: (2024-02-01)

Neuroactive Multifunctional Tacrine Congeners with Cholinesterase, Anti-Amyloid Aggregation and Neuroprotective Properties
by: Maria Kozurkova, et al.
Published: (2011-02-01)

β-Barrels and Amyloids: Structural Transitions, Biological Functions, and Pathogenesis
by: Anna I. Sulatskaya, et al.
Published: (2021-10-01)

The association of circulating amylin with β‐amyloid in familial Alzheimer's disease
by: Han Ly, et al.
Published: (2021-01-01)

β-secretase inhibitor; a promising novel therapeutic drug in AD
by: Kelly Willemijn Menting, et al.
Published: (2014-07-01)

The genetic landscape for amyloid beta fibril nucleation accurately discriminates familial Alzheimer’s disease mutations
by: Mireia Seuma, et al.
Published: (2021-02-01)

Molecular imaging agents for detection of β-amyloid plaques in Alzheimer’s disease
by: Letícia Quental, et al.
Published: (2013-11-01)

BETA-AMYLOID AS PATHOGENESIS OF ALZHEIMER DISEASE
by: Kadek Ary Mahendri Pattni
Published: (2013-07-01)

Amyloids: The History of Toxicity and Functionality
by: Elmira I. Yakupova, et al.
Published: (2021-05-01)

Evaluation of Amyloid β<sub>42</sub> Aggregation Inhibitory Activity of Commercial Dressings by A Microliter-Scale High-Throughput Screening System Using Quantum-Dot Nanoprobes
by: Masahiro Kuragano, et al.
Published: (2020-06-01)

Lifting the veil on amyloid drug design
by: Kathryn E Tiller, et al.
Published: (2013-07-01)

A Biomimetic Multiparametric Assay to Characterise Anti-Amyloid Drugs
by: Willy Smeralda, et al.
Published: (2023-11-01)

DJ-1 can form β-sheet structured aggregates that co-localize with pathological amyloid deposits
by: Katalin Solti, et al.
Published: (2020-02-01)

Yeast screening platform identifies FDA-approved drugs that reduce Aβ oligomerization
by: Triana Amen, et al.
Published: (2016-03-01)

The Toxicity and Polymorphism of β-Amyloid Oligomers
by: Ya-ru Huang, et al.
Published: (2020-06-01)

Looking for a generic inhibitor of amyloid-like fibril formation among flavone derivatives
by: Tomas Šneideris, et al.
Published: (2015-09-01)

Aryloxypropanolamine targets amyloid aggregates and reverses Alzheimer-like phenotypes in Alzheimer mouse models
by: Hee Yang Lee, et al.
Published: (2022-11-01)

Alzheimer’s Disease: A Brief History of Immunotherapies Targeting Amyloid β
by: Anne-Cathrine S. Vogt, et al.
Published: (2023-02-01)

Unconjugated PLGA nanoparticles attenuate temperature-dependent β-amyloid aggregation and protect neurons against toxicity: implications for Alzheimer’s disease pathology
by: Pallabi Sil Paul, et al.
Published: (2022-02-01)

Dicyano-derivatives as mapping agents for peripheric Aβ plaques in Alzheimer’s disease mouse model
by: Haijun Yang, et al.
Published: (2024-01-01)

Vascular Heparan Sulfate and Amyloid-β in Alzheimer’s Disease Patients
by: Ilayda Ozsan McMillan, et al.
Published: (2024-04-01)

Ethnopharmacological Approaches for Dementia Therapy and Significance of Natural Products and Herbal Drugs
by: Devesh Tewari, et al.
Published: (2018-02-01)

A Systematic Review of Antiamyloidogenic and Metal-Chelating Peptoids: Two Structural Motifs for the Treatment of Alzheimer’s Disease
by: Sherri C. Young
Published: (2018-01-01)

Inhibition of amyloid-β(16–22) aggregation by polyphenols using replica permutation with solute tempering molecular dynamics simulation
by: Daiki Fukuhara, et al.
Published: (2023-12-01)